A duo of experts provide insight on various topics related to the advances in treatment options, diagnosis of the disorder, role of genetics, and potential future research and gene therapies.
In Memoriam: A Loving Tribute to June Halper
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
Case Study Highlights Therapeutic Potential of Tocilizumab in MOGAD With Cancer
Special Episode: FDA Approves Donanemab for Early Symptomatic Alzheimer Disease
Ionis to Advance ION582 in Phase 3 Studies of Angelman Syndrome Following Positive Open-Label Data
NeuroVoices: David Shprecher, DO, MSci, FAAN, on Current and Future Directions in Biomarker Testing for Atypical Parkinsonism